Hydrogels containing redispersible spray-dried melatonin-loaded nanocapsules: A formulation for transdermal-controlled delivery

Nanoscale Research Letters

Volumn 7, Issue , 2012, Pages

  Hoffmeister, Cristiane R D ^a   Durli, Taís L ^a   Schaffazick, Scheila R ^b   Raffin, Renata P ^a,c   Bender, Eduardo A ^a   Beck, Ruy C R ^a   Pohlmann, Adriana R ^a   Guterres, Sílvia S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^c CENTRO UNIVERSITÁRIO FRANCISCANO   (Brazil)

Author keywords

Hydrogels; Lactose; Maltodextrin; Melatonin; Nanocapsules; Skin permeation; Spray drying; Transdermal delivery

Indexed keywords

DIALYSIS MEMBRANES; HORMONES; HYDROGELS; HYDROPHILICITY; NANOCAPSULES; POLYSACCHARIDES; SPRAY DRYING; SUGARS; TARGETED DRUG DELIVERY;

LACTOSE; MALTODEXTRINS; MELATONIN; SKIN PERMEATION; TRANSDERMAL DELIVERY;

CONTROLLED DRUG DELIVERY;

SUS;

EID: 84864004869     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-7-251     Document Type: Article

References (41)

1. Beyer CE, Steketee JD, Saphier D: Antioxidant properties of melatonin - an emerging mystery. Biochem Pharmacol 1998, 56:1265-1272.
2. Brömme HJ, Mörke W, Peschke E, Ebelt H, Peschke D: Scavenging effect of melatonin on hydroxyl radicals generated by alloxan. J Pineal Res 2000, 29:201-208.
3. Teixeira A, Morfim MP, de Cordova CAS, Charão CCT, de Lima VR, Creczynski-Pasa TB: Melatonin protects against pro-oxidant enzymes and reduces lipid peroxidation in distinct membranes induced by the hydroxyl an ascorbyl radicals and by peroxynitrite. J Pineal Res 2003, 35:262-268.
4. Pappolla MA, Simovich MJ, Bryant-Tomas T, Chyan Y-J, Poeggler B, Dubocovich M, Bick R, Perry G, Cruz-Samchez F, Simith MA: The protective activities of melatonin against the Alzheimer β-protein are not mediated by melatonin membrane receptors. J Pineal Res 2002, 32:135-142.
5. Reiter RJ, Tan D-X: Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 2003, 58:10-19.
6. Vijayalaximi CRT, Reiter RJ, Herman TS: Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 2002, 20:2575-2601.
7. Lee B-J, Ryu S-G, Cui J-H: Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin. Drug Dev Ind Pharm 1999, 25:493-501.
8. El-Gibaly I, Meki AMA, Abdel-Ghaffar SK: Novel B melatonin-loaded chitosan microcapsules: in vitro characterization and antiapoptosis efficacy for aflatoxin B1-induced apoptosis in rat liver. Int J Pharm 2003, 260:5-22.
9. Kumar A, Agarwal SP, Khanna R: Modified release bi-layered tablet of melatonin using β-cyclodextrin. Pharmazie 2003, 58:642-644.
10. Lee B-J, Parrot KA, Ayres JW, Sack RL: Design and evaluation of an oral controlled release delivery system form melatonin in human subjects. Int J Pharm 1995, 124:119-127.
11. Lee B-J, Mim G-H: Oral controlled release of melatonin using polymer-reinforced and coated alginate beads. Int J Pharm 1996, 144:37-46.
12. Lee B-J, Parrot KA, Ayres JW, Sack RL: Development and characterization of an oral controlled-release delivery system for melatonin. Drug Dev Ind Pharm 1996, 22:269-274.
13. Lee B-J, Choe JS, Kim C-K: Preparation and characterization of melatonin-loaded stearyl alcohol microspheres. J Microencapsul 1998, 15:775-787.
14. El-Gibaly I: Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheres. Int J Pharm 2002, 249:7-21.
15. Mao S, Chen J, Wei Z, Liu H, Bi D: Intranasal administration of melatonin starch microspheres. Int J Pharm 2004, 272:37-43.
16. Dubey V, Mishra D, Jain NK: Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm 2007, 67:398-405.
17. Dubey V, Mishra D, Asthana A, Jain NK: Transdermal delivery of a pineal hormone: melatonin via elastic liposomes. Biomaterials 2006, 27:3491-3496.
18. Bénès L, Claustrat B, Horrière F, Geoffriau M, Konsil J, Parrott KA, DeGrande G, McQuinn RL, Ayres JW: Transmucosal, oral controlled-release, and transdermal drug administration in human subjects: a crossover study with melatonin. J Pharm Sci 1997, 86:1115-1119.
19. Hafner A, Lovrić J, Voinovich D, Filipović-Grčić J: Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterization and permeability through Caco-2 cell monolayers. Int J Pharm 2009, 381:205-213.
20. Kandimalla KK, Kanikkannan N, Singh M: Optimization of a vehicle mixture for the transdermal delivery of melatonin using artificial neural networks and response surface method. J Contr Release 1999, 61:71-82.
21. Sahoo SK, Labhasetwar V: Nanotech approaches to drug delivery and imaging. Drug Discov Today 2003, 8:1112-1120.
22. Garcia-Garcia E, Andrieux K, Gil S, Couvreur P: Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? Int J Pharm 2005, 298:274-292.
23. Schaffazick SR, Guterres SS, Lucca-Freitas L, Pohlmann AR: Caracterização e estabilidade físico-química de sistemas poliméricos nanoparticulados para administração de fármacos. Quim Nova 2003, 26:726-737.
24. Schaffazick SR, Pohlmann AR, Cordova CAS, Creczyniski-Pasa TB, Guterres SS: Protective properties of melatonin-loaded nanoparticles against lipid peroxidation. Int J Pharm 2005, 289:209-213.
25. Schaffazick SR, Siqueira IR, Badejo AS, Jornada DS, Pohlmann AR, Netto CA, Guterres SS: Incorporation in polymeric nanocapsules improves the antioxidant effect of melatonin against lipid peroxidation in mice brain and liver. Eur J Pharm Biopharm 2008, 69:64-71.
26. Molpeceres J, Aberturas MR, Chacón M, Berges L, Guzmán M: Stability of cyclosporine-loaded poly-epsilon-caprolactone nanoparticles. J Microencapsul 1997, 14:777-787.
27. Guterres SS, Fessi H, Barratt G, Devissaguet J-P, Puisieux P: Poly(DL-lactide) nanocapsules containing diclofenac: I. Formulation and stability study. Int J Pharm 1995, 113:57-63.
28. Calvo P, Vila-Jato JL, Alonso MJ: Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules and nanoemulsions, as ocular drug carriers. J Pharm Sci 1996, 85:530-536.
29. Abdelwahed W, Degobert G, Fessi H: A pilot study of freeze-drying of poly(ε-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization. Int J Pharm 2006, 309:178-188.
30. Lacoulonche F, Gamisans F, Chauvet A, García ML, Espina M, Egea MA: Stability and in vitro drug release of flurbiprofen-loaded poly-ε-caprolactone nanospheres. Drug Dev Ind Pharm 1999, 25:983-993.
31. Schaffazick SR, Pohlmann AR, Guterres SS: Nanocapsules, nanoemulsion and nanodispersion containing melatonin: preparation, characterization and stability evaluation. Pharmazie 2007, 62:354-360.
32. Guterres SS, Beck RCR, Pohlmann AR: Spray-drying technique to prepare innovative nanoparticulate formulations for drug administration: a brief overview. Braz J Phys 2009, 39:205-209.
33. Domingues GS, Guterres SS, Beck RCR, Pohlmann AR: Micropartículas nanorrevestidas contendo um fármaco modelo hidrofóbico: preparação em etapa única e caracterização biofarmacêutica. Quim Nova 2008, 31:1966-1972.
34. Schaffazick SR, Pohlmann AR, Mezzalira G, Guterres SS: Development of nanocapsule suspensions and nanocapsule spray-dried powders containing melatonin. J Braz Chem Soc 2006, 17:562-569.
35. Tewa-Tagne P, Briaçon S, Fessi H: Preparation of redispersible dry nanocapsules by means of spray-drying: Development and characterization. Eur J Pharm Sci 2007, 30:124-135.
36. Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S: Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 1989, 55:R1-R4.
37. Fontana MC, Coradini K, Guterres SS, Pohlmann AR, Beck RCR: Nanoencapsulation as a way to control the release and to increase the photostability of clobetasol propionate: influence of the nanostructured system. J Biomed Nanotechnol 2009, 5:254-263.
38. Jager E, Venturini CG, Poletto F, Colomé LM, Pohlmann JPU, Bernardi A, Battastini AMO, Guterres SS, Pohlmann AR: Sustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface area. J Biomed Nanotechnol 2009, 5:130-140.
39. Beck RCR, Hass SE, Guterres SS, Ré MI, Benvenutti EV, Pohlmann AR: Nanoparticle-coated organic-inorganic microparticles: experimental design and gastrointestinal tolerance evaluation. Quim Nova 2006, 29:990-996.
40. Jakubowicz J: Particle analysis and properties of mechanically alloyed Nd16Fe76-xTixB8. Superlattice and Microst 2008, 43:315-323.
41. Le TT, Saveyn P, Hoa HD, Meeren PV: Determination of head-induced effects on the particle size distribution of casein micelles by dynamic light scattering and nanoparticle tracking analysis. Int Dairy J 2008, 18:1090-1096.